Inhibition of cholesterol absorption by SCH 58053 in the mouse is not mediated via changes in the expression of mRNA for ABCA1, ABCG5, or ABCG8 in the enterocyte

Journal of Lipid Research

Volumn 43, Issue 11, 2002, Pages 1864-1874

  Repa, Joyce J ^b   Dietschy, John M ^a   Turley, Stephen D ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Bile acid; Cholesterol efflux; Cholesterol synthesis; Fecal neutral sterol; Liver; Small intestine

Indexed keywords

1,4 BIS(4 METHOXYPHENYL) 3 (3 PHENYLPROPYL) 2 AZETIDINONE; 7 (4 CHLOROPHENYL) 2 (4 FLUOROPHENYL) 7 HYDROXY 3 (4 HYDROXYPHENYL) 2 AZASPIRO[3.5]NONAN 1 ONE; ANTILIPEMIC AGENT; BILE ACID; CHOLESTEROL; EZETIMIBE; MESSENGER RNA; SCH 58053; STEROL; UNCLASSIFIED DRUG; ABC TRANSPORTER; ABC TRANSPORTER A1; ABCG5 PROTEIN, MOUSE; ABCG8 PROTEIN, MOUSE; AZETIDINE DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; LIPOPROTEIN; SPIRO COMPOUND;

ANIMAL EXPERIMENT; ARTICLE; BILE ACID SYNTHESIS; CHOLESTEROL BILE LEVEL; CHOLESTEROL DIET; CHOLESTEROL LIVER LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; INTESTINE CELL; LIPID ABSORPTION; LIPID COMPOSITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEROL EXCRETION; ABSORPTION; ANIMAL; CHEMICAL STRUCTURE; CHOLESTEROL INTAKE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

ABSORPTION; ANIMALS; ANTICHOLESTEREMIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; AZETIDINES; BILE ACIDS AND SALTS; CHOLESTEROL, DIETARY; ENTEROCYTES; FEMALE; GENE EXPRESSION REGULATION; LIPOPROTEINS; MICE; MOLECULAR STRUCTURE; RNA, MESSENGER; SPIRO COMPOUNDS;

EID: 0036845043     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M200144-JLR200     Document Type: Article

References (58)

1. The Expert Panel. 2001. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel of Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 285: 2486-2497.
2. Turley, S. D., and J. M. Dietschy. 1988. The metabolism and excretion of cholesterol by the liver. In The Liver: Biology and Pathobiology. I. M. Arias, W. B. Jakoby, H. Popper, D. Schachter, and D. A. Shafritz, editors. Raven Press, New York. 617-641.
3. McMurry, M. P, W. E. Connor, D. S. Lin, M. T. Cerqueira, and S. L. Connor. 1985. The absorption of cholesterol and the sterol balance in the Tarahumara Indians of Mexico fed cholesterol-free and high cholesterol diets. Am. J. Clin. Nutr. 41: 1289-1298.
4. Kesäniemi, Y. A., and T. A. Miettinen. 1987. Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population. Eur. J. Clin. Invest. 17: 391-395.
5. Bhattacharyya, A. K., and D. A. Eggen. 1980. Cholesterol absorption and turnover in rhesus monkeys as measured by two methods. J. Lipid Res. 21: 518-524.
6. St. Clair, R. W., L. L. Wood, and T. B. Clarkson. 1981. Effect of sucrose polyester on plasma lipids and cholesterol absorption in African green monkeys with variable hypercholesterolemic response to dietary cholesterol. Metabolism. 30: 176-183.
7. Kushwaha, R. S., K. S. Rice, D. S. Lewis, H. C. McGill, Jr., and K. D. Carey. 1993. The role of cholesterol absorption and hepatic cholesterol content in high and low responses to dietary cholesterol and fat in pedigreed baboons (Papio species). Metabolism. 42: 714-722.
8. Turley, S. D., D. K. Spady, and J. M. Dietschy. 1997. Identification of a metabolic difference accounting for the hyper- and hypore-sponder phenotypes of cynomolgus monkey. J. Lipid Res. 38: 1598-1611.
9. Bosner, M. S., L. G. Lange, W. F. Stenson, and R. E. Ostlund, Jr. 1999. Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry. J. Lipid Res. 40: 302-308.
10. Carter, C. P., P. N. Howles, and D. Y. Hui. 1997. Genetic variation in cholesterol absorption efficiency among inbred strains of mice. J. Nutr. 127: 1344-1348.
11. Jolley, C. D., J. M. Dietschy, and S. D. Turley. 1999. Genetic differences in cholesterol absorption in 129/Sv and C57BL/6 mice: Effect on cholesterol responsiveness. Am. J. Physiol. 276: G1117-G1124.
12. Schwarz, M., D. L. Davis, B. R. Vick, and D. W. Russell. 2001. Genetic analysis of intestinal cholesterol absorption in inbred mice. J. Lipid Res. 42: 1801-1811.
13. Schwarz, M., D. L. Davis, B. R. Vick, and D. W. Russell. 2001. Genetic analysis of cholesterol accumulation in inbred mice. J. Lipid Res. 42: 1812-1819.
14. Tso, P. 1994. Intestinal lipid absorption. In Physiology of the Gastrointestinal Tract. L. R. Johnson, editor. Raven Press, New York. 1867-1907.
15. Wilson, M. D., and L. L. Rudel. 1994. Review of cholesterol absorption with emphasis on dietary and biliary cholesterol. J. Lipid Res. 35: 943-955.
16. Homan, R., and B. R. Krause. 1997. Established and emerging strategies for inhibition of cholesterol absorption. Curr. Pharm. Des. 3: 29-44.
17. Wang, D. Q-H., F. Lammert, B. Paigen, and M. C. Carey. 1998. Hyposecretion of biliary phospholipids (PL) significantly decreases the intestinal absorption of cholesterol (Ch) in Mdr2(-/-) and (+/-) mice. Gastroenterology. 114: G3744.
18. Wang, D. Q-H., S. Tazuma, D. E. Cohen, and M. C. Carey. 1999. Natural hydrophilic bile acids profoundly inhibit intestinal cholesterol absorption in mice. Hepatology. 30: 395A.
19. Schwarz, M., D. W. Russell, J. M. Dietschy, and S. D. Turley. 2001. Alternate pathways of bile acid synthesis in the cholesterol 7α-hydroxylase knockout mouse are not upregulated by either cholesterol or cholestyramine feeding. J. Lipid Res. 42: 1594-1603.
20. Turley, S. D., M. W. Herndon, and J. M. Dietschy. 1994. Reevaluation and application of the dual-isotope plasma ratio method for the measurement of intestinal cholesterol absorption in the hamster. J. Lipid Res. 35: 328-339.
21. Young, S. G., C. M. Cham, R. E. Pitas, B. J. Burri, A., Connolly, L. Flynn, A. S. Pappu, J. S. Wong, R. L. Hamilton, and R. V. Farese, Jr. 1995. A genetic model for absent chylomicron formation: Mice producing apolipoprotein B in the liver, but not in the intestine. J. Clin. Invest. 96: 2932-2946.
22. Kramer, W., H. Glombik, S. Petry, H. Heuer, H-L. Schäfer, W. Wendler, D. Corsiero, F. Girbig, and C. Weyland. 2000. Identification of binding proteins for cholesterol absorption inhibitors as components of the intestinal cholesterol transporter. FEBS Lett. 487: 293-297.
23. Hernandez, M., J. Montenegro, M. Steiner, D. Kim, C. Sparrow, P. A. Detmers, S. D. Wright, and Y-S. Chao. 2000. Intestinal absorption of cholesterol is mediated by a saturable, inhibitable transporter. Biochim. Biophys. Acta. 1486: 232-242.
24. Hauser, H., J. H. Dyer, A. Nandy, M. A. Vega, M. Werder, E. Bieliauskaite, F. E. Weber, S. Compassi, A. Gemperli, D. Boffelli, E. Wehrli, G. Schulthess, and M. C. Phillips. 1998. Identification of a receptor mediating absorption of dietary cholesterol in the intestine. Biochemistry. 37: 17843-17850.
25. Mardones, P., V. Quiñones, L. Amigo, M. Moreno, J. F. Miquel, M. Schwarz, H. E. Miettinen, B. Trigatti, M. Krieger, S. VanPatten, D. E. Cohen, and A. Rigotti. 2001. Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type 1-deficient mice. J. Lipid Res. 42: 170-180.
26. Altmann, S. W., H. R. Davis, Jr., X. Yao, M. Laverty, D. S. Compton, L.-j. Zhu, J. H. Crona, M. A. Caplen, L. M. Hoos, G. Tetzloff, T. Priestley, D. A. Burnett, C. D. Strader, and M. P. Graziano. 2002. The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption. Biochim. Biophys. Acta. 1580: 77-93.
27. Berge, K. E., H. Tian, G. A. Graf, L. Yu, N. V. Grishin, J. Schultz, P. Kwiterovich, B. Shan, R. Barnes, and H. H. Hobbs. 2000. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science. 290: 1771-1775.
28. Lee, M.-H., K. Lu, S. Hazard, H. Yu, S. Shulenin, H. Hidaka, H. Kojima, R. Allikmets, N. Sakuma, R. Pegoraro, A. K. Srivastava, G. Salen, M. Dean, and S. B. Patel. 2001. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat. Genet. 27: 79-83.
29. Salen, G., I. Horak, M. Rothkopf, J. L. Cohen, J. Speck, G. S. Tint, V. Shore, B. Dayal, T. Chen, and S. Shefer. 1985. Lethal atherosclerosis associated with abnomal plasma and tissue sterol composition in sitosterolemia with xanthomatosis. J. Lipid Res. 26: 1126-1133.
30. Lütjohann, D., I. Björkhem, U. F. Beil, and K. von Bergmann. 1995. Sterol absorption and sterol balance in phytosterolemia evaluated by deuterium-labeled sterols: Effect of sitostanol treatment. J. Lipid Res. 36: 1763-1773.
31. Bays, H. E., P. B. Moore, M. A. Drehobl, S. Rosenblatt, P. D. Toth, C. A. Dujovne, R. H. Knopp, L. J. Lipka, A. P. LeBeaut, B. Yang, L. E. Mellars, C. Cuffie-Jackson, and E. P. Veltri. 2001. Effectiveness and tolerability of ezetimibe in patients with primary hypercholes-terolemia: Pooled analysis of two phase II studies. Clin. Ther. 23: 1209-1230.
32. Dujovne, C. A., H. Bays, M. H. Davidson, R. Knopp, D. B. Hunninghake, E. A. Stein, A. C. Goldberg, P. Jones, L. J. Lipka, and C. Cuffie-Jackson. 2001. Reduction of LDL cholesterol in patients with primary hypercholesterolemia by SCH 48461: Results of a multicenter dose-ranging study. J. Clin. Pharmacol. 41: 70-78.
33. Gagné, C., D. Gaudet, and E. Bruckert. 2002. Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia. Circulation. 105: 2469-2475.
34. Sudhop, T., D. Lutjohann, A. Kodal, D. Tribble, S. Shah, I. Perevozskaya, and K. von Bergmann. 2002. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Atheroscler. Suppl. 3: 213.
35. Salisbury, B. G., H. R. Davis, R. E. Burrier, D. A. Burnett, G. Boykow, M. A. Caplen, A. L. Clemmons, D. S. Compton, L. M. Hoos, D. G. McGregor, R. Schnitzer-Plokoff, A. A. Smith, B. C. Weig, D. L. Zilli, J. W. Clader, and E. J. Sybertz. 1995. Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461. Atherosclerosis. 115: 45-63.
36. Van Heek, M., C. F. France, D. S. Compton, R. L. McLeod, N. P. Yumibe, K. B. Alton, E. J. Sybertz, and H. R. Davis, Jr. 1997. In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461. J. Pharmacol. Exp. Ther. 283: 157-163.
37. Van Heek, M., T. M. Austin, C. Farley, J. A. Cook, G. G. Tetzloff, and H. R. Davis. 2001. Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperin-sulinemic hamsters. Diabetes. 50: 1330-1335.
38. Davis, H. R., Jr., K. K. Pula, K. B. Alton, R. E. Burrier, and R. W. Watkins. 2001. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in dogs. Metabolism. 50: 1234-1241.
39. Van Heek, M., D. S. Compton, and H. R. Davis. 2001. The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys. Eur. J. Pharmacol. 415: 79-84.
40. Davis, H. R., Jr., D. S. Compton, L. Hoos, and G. Tetzloff. 2001. Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in apoE knockout mice. Arterioscler. Thromb. Vasc. Biol. 21: 2032-2038.
41. Van Heek, M., C. Farley, D. S. Compton, L. Hoos, K. B. Alton, E. J. Sybertz, and H. R. Davis, Jr. 2000. Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663. Br. J. Pharmacol. 129: 1748-1754.
42. Schwarz, M., D. W. Russell, J. M. Dietschy, and S. D. Turley. 1998. Marked reduction in bile acid synthesis in cholesterol 7α-hydroxylase deficient mice does not lead to diminished tissue cholesterol turnover or to hypercholesterolemia. J. Lipid Res. 39: 1833-1843.
43. Repa, J. J., G. Liang, J. Ou, Y. Bashmakov, J-M. A. Lobaccaro, I. Shimomura, B. Shan, M. S. Brown, J. L. Goldstein, and D. J. Mangelsdorf. 2000. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ. Genes Dev. 14:2819-2830.
44. Miettinen, T. A. 2001. Cholesterol absorption inhibition: A strategy for cholesterol-lowering therapy. Int. J. Clin. Pract. 55: 710-716.
45. Turley, S. D., M. Schwarz, D. K. Spady, and J. M. Dietschy. 1998. Gender-related differences in bile acid and sterol metabolism in outbtbrred CD-1 mice fed low- and high-cholesterol diets. Hepatology. 28: 1088-1094.
46. Crouse, J. R., and S. M. Grundy. 1979. Effects of sucrose polyester on cholesterol metabolism in man. Metabolism. 28: 994-1000.
47. Turley, S. D., B. P. Daggy, and J. M. Dietschy. 1991. Cholesterol-lowering action of psyllium mucilloid in the hamster: Sites and possible mechanisms of action. Metabolism. 40: 1063-1073.
48. Turley, S. D., D. K. Spady, and J. M. Dietschy. 1997. Regulation of fecal bile acid excretion in male golden syrian hamsters fed a cereal based diet with and without added cholesterol. Hepatology. 25: 797-803.
49. Crouse, J. R., S. M. Grundy, and J. H. Johnson. 1982. Effects of AOMA on cholesterol metabolism in man. Metabolism. 31: 733-739.
50. Mok, H. Y. I., K. von Bergmann, and S. M. Grundy. 1977. Regulation of pool size of bile acids in man. Gastroenterology. 73: 684-690.
51. Bennion, L. J., E. Drobny, W. C. Knowler, R. L. Ginsberg, M. B. Garnick, R. D. Adler, and W. C. Duane. 1978. Sex differences in the size of bile acid pools. Metabolism. 27: 961-969.
52. Repa, J. J., S. D. Turley, J-M. A. Lobaccaro, J. Medina, L. Li, K. Lustig, B. Shan, R. A. Heyman, J. M. Dietschy, and D. J. Mangelsdorf. 2000. Regulation of absorption and ABCl-mediated efflux of cholesterol by RXR heterodimers. Science. 289: 1524-1529.
53. Buhman, K. K., M. Accad, S. Novak, R. S. Choi, J. S. Wong, R. L. Hamilton, S. D. Turley, and R. V. Farese, Jr. 2000. Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice. Nat. Med. 6: 1341-1347.
54. Dean, M., Y. Hamon, and G. Chimini. 2001. The human ATP-binding cassette (ABC) transporter superfamily. J. Lipid Res. 42: 1007-1017.
55. Dietschy, J. M., and S. D. Turley. 2002. Control of cholesterol turnover in the mouse. J. Biol. Chem. 277: 3801-3804.
56. Dietschy, J. M., S. D. Turley, and D. K. Spady. 1993. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J. Lipid Res. 34: 1637-1659.
57. Osono, Y., L. A. Woollett, J. Herz, and J. M. Dietschy. 1995. Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse. J. Clin. Invest. 95: 1124-1132.
58. Xie, C., L. A. Woollett, S. D. Turley, and J. M. Dietschy. 2002. Fatty acids differentially regulate hepatic cholesteryl ester formation and incorporation into lipoproteins in the liver of the mouse. Lipid Res. 43: 1508-1519.